Tailored Drug Titration Through Artificial Intelligence

Withdrawn before enrolling · Not applicable

Conditions studied: Hypertension

In brief

ARTERY is a randomized clinical trial that investigates the benefit of a predictive modeling artificial intelligence in improving the management of anti-hypertensive medication treatment.

Key facts

Study ID

NCT03397524

Run by

Optima Integrated Health

People needed

0

Starts

2018-10-01

Expected to finish

2020-03-31

Last updated by the study team

2019-09-20

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Two or more blood pressure readings of ≥ 150/95 mmHg during primary care office visits in the Department of General Medicine within the last 6 months
• Therapy with medications from at least 1 anti-hypertensive pharmacological agents at the time of the last office visit
• At least minimally "tech-savvy" defined as Ownership of a compatible smartphone Ability to access the internet

You may not qualify if…

• Inability to operate a blood pressure cuff
• Incompatible smartphone device (Galaxy S5 Android 5.0)
• Less than minimally "tech-savvy," defined as inability to use the Internet
• Non-compliance with medical follow-up (frequent "no shows")
• Planned coronary revascularization in the next 12 months
• Myocardial infarction, coronary revascularization, stroke, cardiac or aortic surgery in the previous 90 days
• GFR < 30 (CKD stage IV/ V)
• Primary care provider rules out the patient due to comorbidities or other factors

Where it is running

• University of California San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.